Amethis portfolio company makes healthcare acquisition

Best Health, a portfolio company of Amethis Maghreb Fund I, has finalised the acquisition of Mabiotech, a distributor of in-vitro diagnostic devices and reagents for public and private medical laboratories.

Best Health is involved in the distribution and instalment of medical equipment for hospitals and clinics in Morocco and Tunisia.

Mabiotech has a comprehensive line of products covering the industry’s most important specialties, including immunology, biochemistry, hematology and microbiology. For Mabiotech, this acquisition represents an opportunity to become part of a well-established player in the market, expanding its Moroccan and African customer portfolio and benefiting from the Best Health network.

Reach Africa’s private equity community by publishing a Showcase Article, Job Opportunity or Event on Africa Private Equity News. Contact us at editor@africaprivateequitynews.com for our rate card and more information.